Dec. 4, 2017 – A new report from the National Academies of Science, Engineering and Medicine, “Making Medicines Affordable,” recommends promoting the adoption of industry codes of conduct, eliminating the tax deductibility of advertising expenses and discouraging direct-to-consumer (DTC) advertising in order to lower drug prices (http://bit.ly/2zX0jq7). “In yet another example of drug marketing being […]
Read more
Nov. 30, 2017 – False or misleading risk presentation and claims about efficacy were the primary concerns listed in the Office of Prescription Drug Promotion’s (OPDP’s) second Warning Letter of the year, demonstrating that the issues cited in previous years’ enforcement letters remain a priority for the agency. “While this is only the third enforcement […]
Read more
Nov. 28, 2017 – The Coalition for Healthcare Communication supports Alex Azar to become the next Department of Health and Human Services (HHS) Secretary, according to a Nov. 28 letter from the CHC to Sen. Lamar Alexander (R-Tenn.), chairman of the Senate Committee on Health, Education, Labor & Pensions (HELP), and Sen. Patty Murray (D-Wash.), […]
Read more
Nov. 13, 2017 – While it seemed like the elimination of the pharma advertising tax deduction was not on the tax bill table, Sen. Claire McCaskill (D-Mo.) today filed an amendment to eliminate that tax deduction. “Although we’re taking this seriously, a Senate Democrat filing an amendment to a Republican-controlled bill is perhaps not a […]
Read more
Nov. 2, 2017 – In a memo sent to Coalition for Healthcare Communication members today, CHC Executive Director John Kamp reported that the Republican tax bill just announced “DOES NOT contain a provision to reduce the immediate deductibility of marketing costs, meaning we survived the first hurdle in this tax bill. Kamp told Coalition members […]
Read more
Oct. 30, 2017 – FDA Commissioner Scott Gottlieb, M.D., is taking a strong leadership position in light of the nation’s opioid crisis, making a statement, in response to President Donald J. Trump’s declaration of the crisis as a public health emergency, that the FDA “has a vital role to play” on this issue, and telling […]
Read more
Oct. 19, 2017 – A New Jersey proposal to both prohibit prescribers from accepting even moderate meals and cap compensation for speeches, consulting or other services from pharmaceutical companies – in an attempt to target the unnecessary prescription of opioids – actually could be counterproductive in meeting that goal, according to Coalition for Healthcare Communication […]
Read more
Oct. 16, 2017 — As the FDA considers the most effective way for pharmaceutical companies to present risks in direct-to-consumer (DTC) ads, a recently published paper in Nature Human Behavior underscores the commonly held belief that consumers do not respond well to a barrage of product risk information. According to the paper abstract, these long […]
Read more Oct. 10, 2017 – Many in the medical marketing industry have already reached out to their members of Congress to express their support for the full and immediate deductibility of all marketing costs, but those who have not need to do so right away, according to Coalition for Healthcare Communication Executive Director John Kamp, who […]
Read more Oct. 2, 2017 – According to a recent poll conducted by POLITICO and Harvard T.H. Chan School of Public Health, 40 percent of those surveyed said that lowering prescription drug prices should be Congress’ number one priority for the remainder of 2017. Just 26 percent of the public stated that repealing and replacing Obamacare should […]
Read more